Document Detail


Cost analysis of unilateral and bilateral pallidotomy for Parkinson's disease.
MedLine Citation:
PMID:  15519857     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
With the rapid increase in provision of deep brain stimulation for Parkinson's disease, the efficacy of pallidotomy in symptom alleviation appears to be increasingly ignored. We demonstrate that lesional surgery is effective with benefit over a significant period of time with very significant societal cost savings. Such studies are essential for future planning of services so that maximum numbers of patients can benefit from surgery, both lesional and neuromodulation, as deemed appropriate.
Authors:
A L Green; C Joint; H Sethi; P Bain; T Z Aziz
Related Documents :
20147427 - Cost and impact of a quality improvement programme in mental health services.
10795617 - Mini-percutaneous nephrolithotomy.
10527007 - The effects of lottery incentive and length of questionnaire on health survey response ...
10386487 - Intimate partner violence against women: do victims cost health plans more?
15754467 - Medicare program: changes to the medicare claims appeal procedures. interim final rule ...
18845697 - Broadening the "ports of entry" for speech-language pathologists: a relational and refl...
Publication Detail:
Type:  Clinical Trial; Journal Article    
Journal Detail:
Title:  Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia     Volume:  11     ISSN:  0967-5868     ISO Abbreviation:  J Clin Neurosci     Publication Date:  2004 Nov 
Date Detail:
Created Date:  2004-11-02     Completed Date:  2008-01-17     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9433352     Medline TA:  J Clin Neurosci     Country:  Scotland    
Other Details:
Languages:  eng     Pagination:  829-34     Citation Subset:  IM    
Affiliation:
The Oxford Movement Disorder Group, Department of Neurological Surgery, The Radcliffe Infirmary, Woodstock Road, Oxford OX2 6HE, UK.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Aged
Aged, 80 and over
Antiparkinson Agents / economics,  therapeutic use
Cohort Studies
Costs and Cost Analysis / methods
Female
Humans
Male
Middle Aged
Neurologic Examination
Pallidotomy / economics*,  methods*
Parkinson Disease / drug therapy,  economics*,  surgery*
Severity of Illness Index
Treatment Outcome
Chemical
Reg. No./Substance:
0/Antiparkinson Agents

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Acute complications of dopamine agonist treatment for macroprolactinoma - how uncommon?
Next Document:  CT scan in minor head injury: a guide for rural doctors.